Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Psychological Medicine|February 26, 2025
Resting-state network alterations in depression: a comprehensive meta-analysis of functional connectivityZhihui Zhang, Yijing Zhang, He Wang, et al.
Frontiers in Plant Science|March 21, 2022
Nep1-Like Proteins From the Biocontrol Agent <i>Pythium oligandrum</i> Enhance Plant Disease Resistance Independent of Cell Death and Reactive Oxygen SpeciesKun Yang, Chao Chen, Yi Wang, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 13, 2024
Transcriptional signatures of gray matter volume changes in mild traumatic brain injuryLu Wang, He Wang, Yijing Zhang, et al.
Antimicrobial Agents and Chemotherapy|April 10, 2019
Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological MalignanciesLei Dong, Xiao-Ying Zhai, Yi-Lei Yang, et al.
Cyborg and Bionic Systems (Washington, D.C.)|January 12, 2026
Hemispheric Asymmetry in the Genetic Overlap between Schizophrenia and White Matter MicrostructureYujie Zhang, Mengge Liu, Shaoying Wang, et al.
Plos One|July 14, 2022
Metagenomic analysis of the dynamical conversion of photosynthetic bacterial communities in different crop fields over different growth periodsJu-E Cheng, Pin Su, Zhan-Hong Zhang, et al.
British Journal of Clinical Pharmacology|February 21, 2020
Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemiaYue Zhou, Li Wang, Xiao-Ying Zhai, et al.
American Journal of Translational Research|April 10, 2020
Treatment with soluble bone morphogenetic protein type 1A receptor fusion protein alleviates irradiation-induced bone loss in mice through increased bone formation and reduced bone resorptionShen Wang, Jie Li, Huabei Sun, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 2009
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depressionRobert A Hodgson, Rosalia Bertorelli, Geoffrey B Varty, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2016
Alternative core development around the tetracyclic indole class of HCV NS5A inhibitorsLing Tong, Wensheng Yu, Craig A Coburn, et al.
Pageof 22